On December 1, 2012, dr. P.W. Kamphuisen was appointed professor in Internal Medicine, especially Vascular Medicine, at the University Medical Center Groningen. Kamphuisen focuses his research on three different areas, i.e., risk factors and treatment of thrombosis and pulmonary embolism, efficacy and side effects of new antithrombotic drugs, and the relation between blood coagulation and malignancy.
Pieter Willem Kamphuisen (Rotterdam, 1965) studied Medicine at the University of Leiden. Afterwards he did his PhD research and defended his thesis entitled “ High levels of factor VIII as risk factor of venous thrombosis” at the University of Leiden in 2000. S ubsequently he became a specialist in Internal Medicine, in particular Vascular Medicine. He conducted his specialization at the Rijnstate Ziekenhuis in Arnhem and the UMC St. Radboud in Nijmegen. Kamphuisen worked as research and clinical fellow at the University of Perugia in Italy, and the University of Birmingham in the UK. After working as a staff member at the AMC, in 2011 Kamphuisen was appointed as Head of the Department of Vascular Medicine at the UMCG.
|Last modified:||February 25, 2015 15:56|
August 23, 2016Marthe Walvoort nominated for title of Greatest Dutch/Flemish Scientific Talent
Chemist Marthe Walvoort is in the running for the title of Greatest Dutch/Flemish Scientific Talent. After being nominated by the University of Groningen, she has made it into the final 25 in the competition organized by the New Scientist, an international...
August 18, 2016Research into medical use of ketone drink
Top-level sportsmen and women use sports drinks containing ketones to enhance their performance. The performance-enhancing effect of the drink inspired biochemist/physiologist Jeroen Jeneson from the UMCG to explore its potential for medical use in...
July 15, 2016ERIBA-onderzoekers ontdekken manier om gewone cellen om te zetten in stamcellen
Onderzoekers van het European Institute for the Biology of Ageing (ERIBA) hebben recentelijk een nieuwe methode ontdekt om gewone bloedcellen om te zetten in hematopoiëtische stamcellen.